# CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

Study · id `cardio:ct-nct07276711` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07276711](<https://clinicaltrials.gov/study/NCT07276711>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07276711

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 663 participants.

## Technical summary

Registry record NCT07276711. Randomized; single masking; primary purpose treatment. Start 2026-05-12 (actual); primary completion 2028-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 663 participants (planned count; ClinicalTrials.gov record NCT07276711, source copy `cardio:ctgov-nct07276711-2026-08-26`, retrieved 2026-10-26)
- Started: 2026-05-12 (actual) (ClinicalTrials.gov record NCT07276711, source copy `cardio:ctgov-nct07276711-2026-08-26`, retrieved 2026-10-26)
- Primary completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT07276711, source copy `cardio:ctgov-nct07276711-2026-08-26`, retrieved 2026-10-26)
- Completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT07276711, source copy `cardio:ctgov-nct07276711-2026-08-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07276711, source copy `cardio:ctgov-nct07276711-2026-08-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07276711-2026-08-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
- Condition: Aortic Valve Stenosis
- Condition: Aortic Stenosis
- Condition: Aortic Valve Disease
- Intervention (Device): EmStop Embolic Protection System
- Intervention (Device): Boston Scientific Sentinel
- Lead sponsor: EmStop Inc
- Lead sponsor class: INDUSTRY
- Collaborator: Bright Research Partners
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Bright Research Partners (`cardio:org-bright-research-partners`)

## Provenance

Content hash: 476c01bc40bab0efe7160d5324d3a470433fed4903ac410d78d56d8e62f90c9f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
